The dynamic range of circulating tumor DNA in metastatic breast cancer

INTRODUCTION: The management of metastatic breast cancer needs improvement. As clinical evaluation is not very accurate in determining the progression of disease, the analysis of circulating tumor DNA (ctDNA) has evolved to a promising noninvasive marker of disease evolution. Indeed, ctDNA was repor...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Breast Cancer Res
Auteurs principaux: Heidary, Maryam, Auer, Martina, Ulz, Peter, Heitzer, Ellen, Petru, Edgar, Gasch, Christin, Riethdorf, Sabine, Mauermann, Oliver, Lafer, Ingrid, Pristauz, Gunda, Lax, Sigurd, Pantel, Klaus, Geigl, Jochen B, Speicher, Michael R
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303230/
https://ncbi.nlm.nih.gov/pubmed/25107527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-014-0421-y
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires